¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"dystonia lenticularis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ansa lenticularis
    ·»Áî°í¸®
  • dystonia
    ±Ù(À°)±äÀåÀÌ»ó(Áõ)
  • dystonia musculorum deformans
    º¯Çü±Ù(À°)±äÀåÀÌ»óÁõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dystonia
    ±ÙÀ°±äÀåÀÌ»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ansa lenticularis
    ·»Áî°í¸®
  • dermatofibrosis lenticularis desseminata
    ÆÄÁ¾·»ÁîÇǺμ¶À¯Áõ
  • dystonia
    ±ÙÀ°±äÀåÀÌ»ó
  • dystonia musculorum deformans
    º¯Çü±ÙÀ°±äÀåÀÌ»óÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cranial dystonia
    µÎ°³ÀÌ ±äÀåÁõ
  • hemiplegic dystonia
    Æí¸¶ºñ¼º À̱äÀåÁõ.
  • ansa lenticularis
    ·»Áî°í¸®
  • hyperkeratosis lenticularis perstans
    Áö¼Ó¼º ·»Áî¸ð¾ç °ú°¢È­Áõ
  • processus lenticularis ³ª
    ±ä´Ù¸®³¡, µÎ»óµ¹±â(ÔçßÒÔÍÑÃ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ansa lenticularis
    ·»Áî°í¸®
  • dermatofibrosis lenticularis desseminata
    ¹ü¹ß¼º ¼öÁ¤Ã¼¾ç ÇǺΠ¼¶À¯Áõ
  • fascia lenticularis
    ·»Áî´Ù¹ß
  • hyperkeratosis lenticularis perstans
    Áö¼Ó¼º ·»Áî¸ð¾ç °ú°¢È­Áõ
  • lenticular process<³ª> processus lenticularis
    µÎ»óµ¹±â(ÔçßÒÔÍÑÃ).
  • melanosis lenticularis progressiva ³ª
    »ö¼Ò¼º°ÇÇÇÁõ
  • nucleus of ansa lenticularis
    ·»Áî°í¸®ÇÙ
  • processus lenticularis ³ª
    ±ä´Ù¸®³¡, µÎ»óµ¹±â(ÔçßÒÔÍÑÃ).
  • cranial dystonia
    µÎ°³±Ù±äÀåÀÌ»ó(Áõ)(ÔéËÒÐÉÑÌíåì¶ßÈñø)
  • dystonia
    ±Ù±äÀå°ï¶õÁõ
  • dystonia
    µð½ºÅä´Ï¾Æ, À̱äÀåÁõ, ±Ù±äÀåÀÌ»ó.
  • dystonia
    ±Ù±äÀåÀÌ»ó
  • dystonia musculorum
    ±Ù±äÀåºÎÀüÁõ(ÐÉÑÌíåÝÕîïñø).
  • dystonia musculorum deformans
    º¯Çü¼º ±Ù±äÀåºÎÀüÁõ(ܨû¡àõÐÉÑÌíåÝÕîïñø).
  • flexion dystonia
    ±¼°î¼º ½ÇÁ¶(Áõ)(¡­àõã÷ðàñø).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Ansa lenticularis
    ·»Áî°í¸®
    [¿¾ ¿ë¾î] ·»ÁîÇÙ°í¸®
  • Nucleus of ansa lenticularis
    ·»Áî°í¸®ÇÙ
    [¿¾ ¿ë¾î] ·»ÁîÇÙ°í¸®ÇÙ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dystonia
    µð½ºÅä´Ï¾Æ, À̱äÀåÁõ, ±Ù±äÀåÀÌ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HLP hepatic lipoperoxidation; hind leg paralysis; holoprosencephaly; hyperkeratosis lenticularis perstan...
DMD disease-modifying drug; Doctor of Dental Medicine; Duchenne muscular dystrophy; dystonia musculorum ...
DRD dihydroxyphenylalanine-responsive dystonia; dorsal root dilator
ITD idiopathic torsion dystonia; intensely transfused dialysis; iodothyronine deiodinase
NCD National Commission on Diabetes; National Council on Drugs; neurocirculatory dystonia; nitrogen clea...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CD Cervical dystonia
DRD DOPA responsive dystonia
ITD Idiopathic torsion dystonia
OMD Oromandibular dystonia
NCD neurocirculatory dystonia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ansa lenticularis
    ·»Áî °í¸®, ·»Áî ÇÙ°èÁ¦
    ·»Áî ÇÙÀÇ ´ãⱸ¿¡¼­ ½ÃÀÛÇÏ¿© ³»Ç¥ÀÇ ³»¿¬À» µ¹¾Æ¼­ Àü½Ã»ó ÇÙÀÇ ¾ÕºÎºÐ¿¡ µµ´ÞÇÏ´Â ¼Ò¼¶À¯·Î.
  • cranial dystonia
    µÎ°³ ±Ù±äÀå ÀÌ»óÁõ
  • dystonia
    ±Ù±äÀå ÀÌ»ó, À̱äÀåÁõ
    1. º¸Åë ±ÙÁ¶Á÷¿¡¼­ÀÇ ºñÁ¤»óÀûÀÎ ±äÀåµµ·Î¼­ ¿îµ¿°ú ÀÚ¼¼ÀÇ º¯È­¸¦ À¯¹ßÇÑ´Ù. 2. °íÁ¤µÈ ÀÌ»óÇÑ ÀÚ¼¼¸¦ ÀÏÀ¸Å°´Â Áõ°¡µÈ ±Ù±äÀåÀ» °¡¸®Å²´Ù.
  • dystonia musculorum deformans
    º¯Çü¼º ±Ù±äÀå ºÎÀüÁõ
    µå¹® À¯Àüº´, ü°£, »çÁö ±ÙÀ°ÀÇ ºÒ¼öÀÇÀû, ºÒ±ÔÄ¢Àû °£´ë¼º °æ·ÃÀ» Ư¡À¸·Î º¸ÀδÙ, Áõ»óÀº ÁÖ·Î º¸Çà¿¡ ³ªÅ¸³ª¸ç ½Åü¸¦ ÀüÈÄ Á¿ì·Î ÀÌ»óÇÏ°Ô ²Á´Ù. »ó¿°»öü ¿­¼ºÇüÀº »çÃá±â Àü¿¡ ÁÖ·Î À¯ÅÂÀο¡°Ô¼­ ³ªÅ¸³ª¸ç, »ó¿°»öü ¿ì¼ºÇüÀº ´õ¿í ´Ê°Ô ³ªÅ¸³­´Ù. ÀÌ Áõ»óÀÇ Á¤µµ´Â ÀÏÁ¤ÇÏÁö ¾Ê´Ù.
  • focal dystonia
    ±¹¼Ò¼º ±Ù±äÀå ÀÌ»ó
    ÀÌȯµÈ ±ÙÀ°¿¡¼­ ÀϽÃÀûÀ¸·Î Áö¼ÓµÇ´Â °æÃàÀÌ Æ¯Â¡ÀÎ ±¹¼ÒÀûÀÎ ±Ù ±äÀå ÀÌ»ó.
  • mandibular dystonia
    ÇÏ¾Ç ±äÀå ÀÌ»ó
    ÇϾÇÀ» Æ÷ÇÔÇÏ´Â ±Ù ±äÀå ÀÌ»ó.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
dystonia lenticularis Dystonia resulting from a lesion of the lenticulate nucleus.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
ansa lenticularis The pallidal efferent fibres curving around the medial border of the internal capsule.
Synonym: ansa lenticularis, lenticular ansa.
(05 Mar 2000)
processus lenticularis incudis A knob at the tip of the long limb of the incus which articulates with the stapes.
Synonym: processus lenticularis incudis, lenticular apophysis, lenticular bone, orbicular bone, orbicular process, orbiculare, os orbiculare, os sylvii.
(05 Mar 2000)
hyperkeratosis lenticularis perstans Small keratotic papules on the dorsa of the feet and legs, and occasionally elsewhere, with pinpoint keratotic papules of the palms and soles; onset in the fourth and fifth decades; possibly an autosomal dominant trait.
Synonym: Flegel's disease.
(05 Mar 2000)
dermatofibrosis lenticularis disseminata Small papules or discs of increased dermal elastic tissue appearing in early life; when osteopoikilosis is also present, the condition is called osteodermatopoikilosis or Buschke-Ollendorf syndrome; autosomal dominant inheritance.
(05 Mar 2000)
fasciculus lenticularis The pallidal efferent fibres that cross the internal capsule and are insinuated between the subthalamic nucleus and zona incerta; they join in the formation of the thalamic fasciculus.
See: lenticular loop.
Synonym: fasciculus lenticularis.
(05 Mar 2000)
cranial dystonia <neurology> A term used to describe dystonia that affects the muscles of the head, face, and neck.
Oromandibular dystonia affects the muscles of the jaw, lips, and tongue. The jaw may be pulled either open or shut, and speech and swallowing can be difficult. Spasmodic dysphonia involves the muscles of the throat that control speech. Also called spastic dysphonia or laryngeal dystonia, it causes strained and difficult speaking or breathy and effortful speech. Meige's syndrome is the combination of blepharospasm and oromandibular dystonia and sometimes spasmodic dysphonia. Spasmodic torticollis can be classified as a type of cranial dystonia.
(12 Dec 1998)
segawa's dystonia An important variant of dopa-responsive dystonia (drd). Typically, drd begins in childhood or adolescence with progressive difficulty in walking and, in some cases, spasticity. In segawa's dystonia, the symptoms fluctuate during the day from relative mobility in the morning to increasingly worse disability in the afternoon and evening as well as after exercise.
(12 Dec 1998)
dementia-nuchal dystonia A disorder that is associated with nerve cell destruction and progressive lack of coordination, neck stiffness, trunk stiffness, problems with eye movement and mild dementia. Disorders that are similar include Alzheimer's disease, cerebellar dysfunction, Jakob-Creutzfeldt disease and Parkinson's disease. The cause for progressive supranuclear palsy is unknown, but is likely a degenerative nerve disorder that is somehow triggered by a viral infection. Pathologic changes include nerve cell damage and destruction of myelin sheath. There is no known cure.
(27 Sep 1997)
dopa-responsive dystonia A condition successfully treated with drugs. Typically, DRD begins in childhood or adolescence with progressive difficulty in walking and, in some cases, spasticity. Segawa's dystonia is an important variant of DRD. In Segawa's dystonia, the symptoms fluctuate during the day from relative mobility in the morning to increasingly worse disability in the afternoon and evening as well as after exercise. Some scientists feel DRD is not only rare but also rarely diagnosed since it mimics many of the symptoms of cerebral palsy.
(12 Dec 1998)
dystonia <clinical sign, neurology> Disordered tonicity of muscle.
Origin: Gr. Tonos
(18 Nov 1997)
dystonia, cranial A term used to describe dystonia that affects the muscles of the head, face, and neck. Oromandibular dystonia affects the muscles of the jaw, lips, and tongue. The jaw may be pulled either open or shut, and speech and swallowing can be difficult. Spasmodic dysphonia involves the muscles of the throat that control speech. Also called spastic dysphonia or laryngeal dystonia, it causes strained and difficult speaking or breathy and effortful speech. Meige's syndrome is the combination of blepharospasm and oromandibular dystonia and sometimes spasmodic dysphonia. Spasmodic torticollis can be classified as a type of cranial dystonia.
(12 Dec 1998)
dystonia, dopa-responsive A condition successfully treated with drugs. Typically, DRD begins in childhood or adolescence with progressive difficulty in walking and, in some cases, spasticity. Segawa's dystonia is an important variant of DRD. In Segawa's dystonia, the symptoms fluctuate during the day from relative mobility in the morning to increasingly worse disability in the afternoon and evening as well as after exercise. Some scientists feel DRD is not only rare but also rarely diagnosed since it mimics many of the symptoms of cerebral palsy.
(12 Dec 1998)
dystonia, focal, due to blepharospasm The second most common focal dystonia, the involuntary, forcible closure of the eyelids. The first symptoms may be uncontrollable blinking. Only one eye may be affected initially, but eventually both eyes are usually involved. The spasms may leave the eyelids completely closed causing functional blindness even though the eyes and vision are normal.
(12 Dec 1998)
dystonia, focal, due to torticollis Spasmodic torticollis, or torticollis, is the most common of the focal dystonias. In torticollis, the muscles in the neck that control the position of the head are affected, causing the head to twist and turn to one side. In addition, the head may be pulled forward or backward.
(12 Dec 1998)
dystonia, idiopathic torsion A form of dystonia known as early-onset torsion dystonia (also called generalised torsion dystonia) begins in childhood around the age of 12. Symptoms typically start in one part of the body, usually in an arm or leg, and eventually spread to the rest of the body within about 5 years. Early-onset torsion dystonia is not fatal, but it can be severely debilitating.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á